DHDavid S. Haydon

David S. Haydon

*This is an algorithmically generated author record based on publicly available information.

David S. Haydon has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Wheelchair Racing Biomechanics and Performance Considerations

    by David S. Haydon, Emma L. Millett

    Wheelchair racing is a key discipline within para-athletics, with athletes across a range of impairment types and functional levels competing across sprints and distance events. Across classifications, the functional level of the athlete often dictates the position within their racing wheelchair they can achieve, and hence the propulsion approach that they use. Even within classifications, athletes may adopt substantially different propulsion approaches depending on their function or impairment. In general, athletes classified as T51 will rely on more trunk stability from their equipment, resulting in a more upright position that uses their biceps heavily throughout their stroke. In comparison, many T54 athletes, where possible, will adopt a kneeling position within their chair, achieving a flatter position that allows some trunk contribution and a push stroke contacting in front of the top centre and releasing past the bottom dead centre. Along with functional differences, this results in large performance variations across classification groups. While the biomechanics of the push stroke is crucial, it is also considered with other performance factors, such as the aerodynamic drag. The development of adjustable fitting and testing systems is expected to improve the ability of wheelchair racers to achieve optimal positions for biomechanics and other performance factors.

  • Open Access

    What gaps exist in biomechanics and motor control research in Paralympic sports? A scoping review focussed on performance and injury risk

    by Robert Lee, Ross A. Pinder, David S. Haydon, Lachlan M. Winter, Robert G. Crowther


  • Open Access

    Genomic tailoring of autogenous poultry vaccines to reduce Campylobacter from farm to fork

    by Jessica Kate Calland, Maiju E. Pesonen, Jai Mehat, Ben Pascoe, David J. Haydon, Jose Lourenco, Evangelos Mourkas, Matthew D. Hitchings, Roberto M. La Ragione, Philip Hammond, et al.

    Campylobacter is a leading cause of food-borne gastroenteritis worldwide, linked to the consumption of contaminated poultry meat. Targeting this pathogen at source, vaccines for poultry can provide short term caecal reductions in Campylobacter numbers in the chicken intestine. However, this approach is unlikely to reduce Campylobacter in the food chain or human incidence. This is likely as vaccines typically target only a subset of the high strain diversity circulating among chicken flocks and rapid evolution diminishes vaccine efficacy over time. To address this, we used a genomic approach to develop a whole-cell autogenous vaccine targeting isolates harbouring genes linked to survival outside of the host. We hyper-immunised a whole major UK breeder farm to passively target offspring colonisation using maternally-derived antibody. Monitoring progeny, broiler flocks revealed a near-complete shift in the post-vaccination Campylobacter population with a ∼50% reduction in isolates harbouring extra-intestinal survival genes and a significant reduction of Campylobacter cells surviving on the surface of meat. Based on these findings, we developed a logistic regression model that predicted that vaccine efficacy could be extended to target 46% of a population of clinically relevant strains. Immuno-manipulation of poultry microbiomes towards less harmful commensal isolates by competitive exclusion, has major potential for reducing pathogens in the food production chain.